In case you missed it

May 10, 2014

Web Version  |  Share with a colleague  |  eNews Subscribe

You are subscribed to the FormularyWatch eNews
In case you missed it
In case you missed it
FormularyWatch

Statin therapy: How safe is it?

The National Lipid Association just released a report addressing 6 safety issues related to statin therapy, including the effects of statins on cognition, diabetes risk, liver function, muscle symptoms, interactions with other drugs, and statin intolerance. Read more

Drug for severe hypertriglyceridemia approved

FDA approved omega-3-carboxylic acids (Epanova, AstraZeneca) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL). Read more
In case you missed it

#icymiTwitter Facebook
In case you missed it

Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.

 Powered by Modern Medicine Advanstar Medical Communications Group